Alten Logo

Alten

ATE | PA

Overview

Corporate Details

ISIN(s):
FR0000071946 (+29 more)
LEI:
969500Y7G9TY7Y24GN07
Country:
France
Address:
40 AVENUE ANDRE MORIZET, 92100 BOULOGNE-BILLANCOURT
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Alten is a global leader in technology consulting, engineering, and IT services. The company specializes in outsourced engineering, research and development (R&D), and IT solutions, supporting the technological and digital transformation of its clients. Its engineers and consultants undertake complex, high-tech projects across the entire value chain for leading companies in the industrial, telecommunications, and service sectors. Services include design and research, software development, IoT integration, data analytics, and cybersecurity. With over 30 years of experience and more than 57,000 employees operating in over 30 countries, Alten delivers its expertise through various models, including project-based contracts and consulting services.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Alten. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-07 17:45
Declaration of Voting Results & Voting Rights Announcements
July 2025
English 252.0 KB
2025-08-07 17:45
Declaration of Voting Results & Voting Rights Announcements
Juillet 2025
French 175.3 KB
2025-06-06 17:45
Share Issue/Capital Change
May 2025
English 251.9 KB
2025-06-06 17:45
Declaration of Voting Results & Voting Rights Announcements
Mai 2025
French 251.9 KB
2025-05-22 17:50
Pre-Annual General Meeting Information
Communiqué de mise à disposition des documents préparatoires - Assemblée Généra…
French 178.2 KB
2025-05-22 17:50
Pre-Annual General Meeting Information
Press release relating to the availability of the preparatory documents - GM to…
English 191.4 KB
2025-05-07 17:45
Declaration of Voting Results & Voting Rights Announcements
April 2025
English 251.5 KB
2025-05-07 17:45
Declaration of Voting Results & Voting Rights Announcements
Avril 2025
French 252.0 KB
2025-04-25 18:00
Registration Form
Availability of the 2024 universal registration document
English 249.7 KB
2025-04-25 18:00
Registration Form
Modalités de mise à disposition du document d’enregistrement universel 2024
French 251.7 KB
2025-04-25 15:44
Annual Report (ESEF)
Document d'enregistrement universel 2024
French 23.9 MB
2025-04-25 10:50
Earnings Release
Erratum only on the press release in English: First quarter 2025 revenue
English 235.4 KB
2025-04-24 17:40
Pre-Annual General Meeting Information
Communiqué relatif à la convocation de l'Assemblée Générale 2025 et au dividend…
French 245.6 KB
2025-04-24 17:40
Notice of Dividend Amount
Press release relating to the 2025 General Meeting and to the 2024 Dividend
English 234.4 KB
2025-04-24 17:40
Earnings Release
GROUPE ALTEN : Activité du premier trimestre 2025
French 215.4 KB

Automate Your Workflow. Get a real-time feed of all Alten filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Alten via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-08-14 N/A Other Sell 1,800 174,870.00 EUR
2024-06-10 N/A Other Sell 700 80,220.00 EUR
2024-03-01 N/A Other Sell 650 89,180.00 EUR
2024-01-02 N/A Other Sell 1,150 156,055.00 EUR
2023-12-21 N/A Other Sell 2,800 373,314.76 EUR
2023-12-15 N/A Other Sell 2,765 369,549.16 EUR
2023-11-08 N/A Other Sell 2,600 306,540.00 EUR
2023-10-27 N/A Other Buy 75,000 8,160,000.00 EUR
2023-10-27 N/A Other Buy 75,000 8,025,000.00 EUR
2023-10-27 N/A Other Buy 6,500 N/A

Peer Companies

Company Country Ticker View
Enlivex Therapeutics Ltd. Logo
Developing a cell therapy platform to treat inflammatory diseases by reprogramming macrophages.
Israel ENLV
E-Novia Logo
A deep-tech factory building Physical AI ventures for mobility, logistics, and automation.
Italy E9IA
ERYTECH Pharma S.A. Logo
Biopharma firm developing phage therapies to fight antimicrobial resistance (AMR).
France ERYP
EUROESPES Logo
Research & patient care for CNS diseases via personalized genomic medicine.
Spain EEP
Eurofins-Cerep Logo
CRO offering preclinical drug profiling, screening & pharmacology testing for pharma/biotech.
France ALECR
Evogene Ltd. Logo
An AI-powered computational biology platform for life-science products in health and agriculture.
Israel EVGN
Evotec SE Logo
A drug discovery and development partner for pharma, biotech, and academia.
Germany EVT
EXACT Therapeutics AS Logo
Biopharma developing ultrasound technology for targeted drug delivery in oncology.
Norway EXTX
ExpreS2ion Biotech Holding AB Logo
Develops vaccines and immunotherapies for infectious diseases and cancer using a protein platform.
Sweden EXPRS2
FARON PHARMACEUTICALS OY Logo
Develops myeloid cell-targeting immunotherapies for solid and hematological cancers.
Finland FARN